Skip to main content

Ergotrate Maleate Side Effects

Generic name: ergonovine

Medically reviewed by Last updated on Aug 19, 2022.

Note: This document contains side effect information about ergonovine. Some dosage forms listed on this page may not apply to the brand name Ergotrate Maleate.

Applies to ergonovine: compounding powder, injectable solution, oral tablet.


Administration of correct dose to carefully selected patients who are closely monitored, yields little risk of serious adverse systemic effects; however, IV administration may produce serious adverse effects if the injections are not diluted and administered slowly.[Ref]


Frequency not reported: Gangrene, coronary artery vasospasm, peripheral vasospasm, hypotension, hypertension, thrombophlebitis, myocardial infarction (single case report), ventricular arrhythmias, transient chest pain, palpitation, bradycardia, vasoconstriction


Very rare (less than 0.01%): Mesenteric ischemia and large bowel infarction (single case report)

Frequency not reported: Abdominal pain, diarrhea, nausea, esophageal spasm, vomiting, unpleasant taste


Frequency not reported: Allergic phenomena (including shock, hypertension, chest pain, palpitation, dyspnea, and bradycardia), anaphylactic/anaphylactoid reaction

Nervous system

Frequency not reported: Dizziness, headache


Frequency not reported: Clinical exacerbations of porphyria, water intoxication


Frequency not reported: Sweating, diaphoresis, skin rashes


Frequency not reported: Dyspnea, nasal congestion, pulmonary edema, pleural thickening


Very rare (less than 0.01%): Unmasking of myasthenia gravis (single case report)

Frequency not reported: Leg cramps

Postmarketing reports: Muscle spasm


Postmarketing reports: Eye movement disorder


Frequency not reported: Hallucinations


Frequency not reported: Hematuria


Frequency not reported: Abnormal liver function test


Frequency not reported: Vertigo, tinnitus


Postmarketing reports: Increased blood creatine

More about Ergotrate Maleate (ergonovine)

Patient resources

Related treatment guides


1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. Cerner Multum, Inc. "Canadian Product Information." O 0 (2015):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.